Skip to main content

Genvor Inc

corporate_fare Company Profile

Genvor Inc

GNVR·OTC·Industrial Applications And Services·CIK 0001792941

Genvor Incorporated is a company focused on sustainable agriculture through AI-accelerated peptide technology. The company, originally named Allure Worldwide, Inc., changed its name to Genvor Incorporated on June 24, 2022. Its primary business operations are conducted through its wholly-owned subsidiary, Genvor Inc., which was incorporated in Delaware on April 4, 2019, initially as Nexion Biosciences Inc., and renamed Genvor Inc. on January 22, 2020. Genvor Inc. acquired Nexion Biosciences LLC (NBLLC) in May 2019; NBLLC was formed on December 28, 2018. The company completed the acquisition of Old Genvor on May 27, 2022, through a merger where Genvor Acquisition Corp., a wholly-owned subsidiary, merged with Old Genvor. As a result, 35,261,871 shares of Company common stock were issued to Old Genvor's pre-merger shareholders. Upon the closing of the acquisition, the Company had 55,261,871 issued and outstanding common shares, and its original founding shareholders subsequently cancelled 18,144,112 shares of Company common stock.

Genvor Inc (OTC:GNVR) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors GNVR SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Genvor Appoints Seasoned CFO with IPO Experience Amidst Going Concern Warning
  • Genvor Reports Substantial Doubt About Going Concern, Material Internal Control Weaknesses, and Ongoing Dilution
  • Genvor Designates Highly Dilutive Series C Preferred Stock, Issues First Share for Advisory Services
  • Genvor Secures Up to $666K Cash and $1.2M Advisory Services via Dilutive Convertible Note and Warrants
  • Genvor Secures Strategic MOU with Canlab for Commercial Peptide Pipeline, Targeting Multi-Million Dollar Revenue Potential

Financial Snapshot

Fiscal year ended September 30, 2025
Net Income
-$5.59M
Diluted EPS
-$0.22
Op. Cash Flow
-$555.72K
Operating Income
-$6.41M
Cash & Equivalents
$37.23K
Total Debt
$20K
Debt / Equity
-0.02×
Shares Outstanding
30.18M sh
Source: 10-K · filed 2025-12-10 · accession 0001903596-25-000575
Browse all tickers starting with G →
$0.51
52-week range · as of 2026-05-21 $0.000001 – $10.01
Volume
6.9K (1.1× avg)
3-mo avg 6.1K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GNVR - Latest Insights

GNVR
May 21, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.458132
Real-time Price: $0.510 info
Change: +$0.051868 (+11%) info
Market Cap: N/A info
GNVR
May 13, 2026, 4:25 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.500
Real-time Price: $0.510 info
Change: +$0.010 (+2%) info
Market Cap: N/A info
GNVR
May 11, 2026, 5:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.510 info
Change: +$0.010 (+2%) info
Market Cap: N/A info
GNVR
Apr 22, 2026, 11:48 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.510 info
Change: +$0.010 (+2%) info
Market Cap: N/A info
GNVR
Apr 14, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.500
Real-time Price: $0.510 info
Change: +$0.010 (+2%) info
Market Cap: N/A info
GNVR
Feb 12, 2026, 10:17 AM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.02
Real-time Price: $0.510 info
Change: -$0.510 (-50%) info
Market Cap: N/A info